Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PSMD9 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
mRNA | RP11-318A15.7 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
mRNA | TBC1D28 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | ABCA5 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | TIAF1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | TCTN3 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | SCML4 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | PDHB | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | SLAMF9 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | ACAT1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |